Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Gross Profit | -23M | 39% |
| Cost of Revenue | 23M | 39% |
| Operating expense | 55M | 41.1% |
| Net Income | -49M | 43.3% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 618M | 5.1% |
| Total Liabilities | 90M | 7.8% |
| Total Equity | 528M | 7% |
| Shares Outstanding | 100M | 0.4% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | -79M | 70.2% |
| Cash from investing | 166M | 286% |
| Cash from financing | 1M | 448.1% |
EPS
Financial Highlights for ACELYRIN in Q3 '24
Gross Profit stood at -23M, marking a -39% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 23M, a 39% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 55M, showing a -41.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -49M, showing a 43.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
ACELYRIN faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
